To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Carol CassCarol Cass is an Canadian research scientist. She is internationally recognized as an expert on nucleosides, an important class of anti-cancer drugs. Her research has led to the more effective use of nucleoside drugs and the development of new treatments for patients with acute and chronic leukemias, lymphomas, and cancers of the lung, bladder, breast and pancreas. Additional recommended knowledgeShe determined that nucleoside-based drugs are able to cross cell membranes by binding to specialized transporter proteins. The drugs are able to enter and directly attack cancer cells during the binding process. Since 2003, Cass has been director of Alberta’s Cross Cancer Institute. She is Canada research chair in oncology at the University of Alberta. Awards
Categories: Canadian medical researchers | Cancer researchers |
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Carol_Cass". A list of authors is available in Wikipedia. |